Long-term therapy with deferiprone

Acta Haematologica
N F Olivieri

Abstract

Data from several trials have provided direct and supportive evidence for the efficacy of deferiprone in the treatment of iron overload in thalassemia major. Deferiprone has been shown to induce sustained decreases in body iron to concentrations associated with survival free from the complications of iron overload in deferoxamine (DFO)-treated patients. Despite this evidence of efficacy, the risk of agranulocytosis mandates a careful evaluation in patients willing and able to use DFO. The incidence of agranulocytosis associated with deferiprone is under study in a prospective multicenter trial in Canada, Italy and the United States, under corporate sponsorship (Apotex Research, Canada). The results of this study should determine the risk associated with the use of this agent, and may provide the data required for an FDA decision regarding licensing of this agent for the treatment of iron overload, a goal supported by investigators worldwide.

Citations

Aug 6, 2009·Annals of Hematology·Inusha PanigrahiRashmi R Das
Jun 19, 2001·Journal of Inorganic Biochemistry·M BorsariF Borella
Mar 2, 1999·Pharmacology & Therapeutics·G F MabezaG Weiss
Oct 8, 1998·Reproductive Toxicology·J L Domingo
Mar 29, 2000·Critical Reviews in Oncology/hematology·D Rund, E Rachmilewitz
Jun 15, 2007·Journal of Medicinal Chemistry·Raymond J BergeronJames R Rocca
Aug 15, 2012·Journal of Medicinal Chemistry·Raymond J BergeronJames S McManis
Jun 7, 2008·Journal of Medicinal Chemistry·Raymond J BergeronShailendra Singh
Sep 16, 2008·Journal of Medicinal Chemistry·Raymond J BergeronShailendra Singh
Jun 20, 1998·British Journal of Haematology·C HershkoG Link
Feb 26, 2000·British Journal of Haematology·A R CohenF Tricta
Jul 9, 2002·British Journal of Haematology·Adriana CeciFernando Tricta
Jul 21, 1998·Annals of the New York Academy of Sciences·A CohenF Tricta
Sep 18, 1997·The Journal of Clinical Investigation·P V BrowneR P Hebbel
Nov 26, 2010·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Raymond J BergeronShailendra Singh
Apr 1, 2011·Expert Opinion on Therapeutic Patents·Hossein HeliKhashayar Karimian
Jun 9, 2010·Hemoglobin·Charalampos Pontikoglou, Helen A Papadaki
Apr 29, 2009·International Journal of Radiation Biology·Raymond J BergeronShailendra Singh
Feb 27, 2016·Pediatric Hematology and Oncology·Burcu Fatma BelenEsma Soylu
Dec 2, 2010·The Korean Journal of Hematology·Sung Chul WonChuhl Joo Lyu
Mar 15, 2003·Blood·A Victor HoffbrandChaim Hershko
Nov 26, 2020·Therapeutic Drug Monitoring·Smita PattanaikJasmina Ahluwalia
Jun 10, 2005·Journal of Medicinal Chemistry·Raymond J BergeronLaszlo Prokai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.